Page last updated: 2024-10-31

methyl methanesulfonate and Ovarian Neoplasms

methyl methanesulfonate has been researched along with Ovarian Neoplasms in 3 studies

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, L1
Chen, DB1
Lin, C1
Cao, K1
Wan, Y1
Zhao, XY1
Nie, CL1
Yuan, Z1
Wei, YQ1
Paik, J1
Duncan, T1
Lindahl, T1
Sedgwick, B1
Smith, DB1
Lind, MJ1
Kaye, SB1
Newlands, ES1
Blackledge, GR1
Gibson, A1

Other Studies

3 other studies available for methyl methanesulfonate and Ovarian Neoplasms

ArticleYear
hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: underlying action mechanism in ovarian cancer cells.
    Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:4

    Topics: Apoptosis; Apoptosis Inducing Factor; Apoptosis Regulatory Proteins; Carbon-Nitrogen Lyases; Caspase

2013
Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.
    Cancer research, 2005, Nov-15, Volume: 65, Issue:22

    Topics: Antineoplastic Agents, Alkylating; Carmustine; Cell Cycle; Dacarbazine; DNA Glycosylases; Female; Ge

2005
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).
    British journal of cancer, 1988, Volume: 57, Issue:5

    Topics: Adult; Aged; Alkylating Agents; Drug Evaluation; Female; Humans; Methyl Methanesulfonate; Middle Age

1988